Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...
Conditions: HIV; Mental Health; Substance Use; STI Interventions: Behavioral: Automated Messaging & Monitoring; Behavioral: Peer Support; Behavioral: Coaching Sponsors: University of California, Los Angeles; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Tulane University Health Sciences Center; University of California, San Francisco; Friends Research Institute, Inc. Recruiting
Conditions: HIV; Mental Health; Illicit Substance Use; Sexually Transmitted Infections (STI) Interventions: Behavioral: Level 1; Behavioral: Level 2; Behavioral: Level 3 Sponsors: University of California, Los Angeles; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Wake Forest University Health Sciences; Tulane University Health Sciences Center; Columbia University Recruiting
Condition: Human Immunodeficiency Virus Intervention: Drug: Antiretrovirals Sponsors: University of California, Los Angeles; Los Angeles LGBT Center; Tulane University Recruiting
Condition: Obesity, Childhood Interventions: Behavioral: eSOC program; Behavioral: FBT program Sponsors: Washington University School of Medicine; Patient-Centered Outcomes Research Institute; Blue Cross Blue Shield of Louisiana; Louisiana Healthcare Connections; American Academy of Pediatrics; Pennington Biomedical Research Center; University of Rochester Recruiting
Condition: Chagas Disease Interventions: Drug: Benznidazole; Drug: Placebo Oral Tablet Sponsors: Tulane University School of Public Health and Tropical Medicine; Institute for Clinical Effectiveness and Health Policy; University of California, San Diego Recruiting
Conditions: Feeding Behavior; Feeding Disorder of Infancy or Early Childhood Interventions: Drug: Megestrol Acetate; Behavioral: iKanEat Behavioral Intervention Sponsor: University of Kansas Medical Center Recruiting
Condition: Bronchopulmonary Dysplasia Interventions: Drug: Sildenafil; Other: Placebo Sponsors: University of North Carolina, Chapel Hill; Duke University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); The Emmes Company, LLC Recruiting
Condition: HIV Infections Interventions: Drug: Dolutegravir (DTG) film-coated tablets; Drug: DTG granules for suspension; Drug: DTG dispersible tablets Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
Condition: Cardiovascular Diseases Intervention: Device: ABIOMED, Inc. hemodynamic support devices Sponsors: Abiomed Inc.; Beth Israel Deaconess Medical Center; Yale University Recruiting
Condition: Hypertension Interventions: Drug: Anti-hypertensive therapy; Other: No anti-hypertensive therapy (unless BP is severe) Sponsors: University of Alabama at Birmingham; Columbia University; Drexel University College of Medicine; Rutgers, The State University of New Jersey; Lehigh Valley Hospital; Saint Peters University Hospital; Christiana Care Health Services; Washington University School of Medicine; Duke University; University of Texas Southwestern Medical Center; The University of Texas Health Science Center, Houston; Stanford University; University of Pennsylvania; The University of Texas Medical Branch, Galveston; University of Utah; Intermountain Health Care, Inc.; University of California, San Francisco; Johns Hopkins University; University of Pittsburgh; Ochsner Health System; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI); WakeMed Health and Hospitals; San Francisco General Hospital; McKay-Dee Hospital; Winthrop University Hospital; New York Hospital Queens; Latter Day Saints Hospital; Lyndon B Johnson General Hospital; Virtua Medical Group; Bayview Medical Center; Duke Regional Hospital; Utah Valley Regional Medical Center; Northwestern; Brown (WIHRI); Baylor College of Medicine; Case Western/Metro Health; Ohio State University; University of Iowa; University of California, San Diego; Indiana University; Unity Point Health-Meriter Hospital WI; Weill Medical College of Cornell University; University of Oklahoma; Medical University of South Carolina; Beaumont Hospital; University of Colorado, Denver; University of Kansas Medical Center; Denver Health and Hospital Authority; Gundersen Health System; Aurora Health Care; Oregon Health and Science University; Medical College of Wisconsin; Temple University; New Jersey Medical School; University of South Alabama; Vanderbilt University; University of Arkansas; Miami Valley Hospital; Emory University; St. Luke's Hospital and Health Network, Pennsylvania; Cleveland Clinic Fairview Hospital; University of Tennessee Health Science Center; TriHealth Inc.; Cleveland Clinic Hillcrest Hospital; Tulane University; Yale University; Arrowhead Regional Medical Center; Geisinger Clinic Recruiting
Conditions: Childhood Malignant Neoplasm; Cognitive Side Effects of Cancer Therapy Interventions: Procedure: Cognitive Assessment; Other: Quality-of-Life Assessment Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Recruiting
Condition: Sickle Cell Disease Interventions: Drug: Busulfan; Drug: Fludarabine; Drug: r-ATG; Procedure: Hematopoietic Cell Transplant; Drug: Tacrolimus; Drug: Methotrexate; Procedure: Standard of Care Sponsors: Medical College of Wisconsin; National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant Clinical Trials Network; Dana-Farber Cancer Institute; National Marrow Donor Program; Emory University Recruiting
Conditions: Metabolic Disorders; Hematologic, Immune, or Bone Marrow Disorders; Hemoglobinopathies; Non-malignant Disorders Interventions: Drug: Treatment Plan 1: Stratum 1; Drug: Treatment Plan 2: Strata 2, 3, or 4; Drug: GVHD Regimen A: UCB Recipients; Drug: GVHD Regimen B: BM Recipients Sponsors: Washington University School of Medicine; St. Louis Children's Hospital Recruiting
Condition: Gonorrhea Interventions: Drug: zoliflodacin; Drug: ceftriaxone; Drug: azithromycin Sponsor: Global Antibiotics Research and Development Partnership Recruiting
Conditions: Status Epilepticus; Convulsive Status EPILEPTICUS; Non Convulsive Status Epilepticus; Epilepsy Interventions: Drug: Ganaxolone; Drug: Placebo Sponsor: Marinus Pharmaceuticals Recruiting
Conditions: Graft-versus-host Disease; Acute-graft-versus-host Disease Interventions: Drug: Defibrotide; Drug: Standard of Care Sponsor: Jazz Pharmaceuticals Recruiting
Conditions: Fecal Microbiota Transplantation; Clostridium Difficile Infection; Gut Microbiome Intervention: Other: None - Observational Sponsors: American Gastroenterological Association; OpenBiome; University of California, San Diego; Icahn School of Medicine at Mount Sinai Recruiting
Condition: Idiopathic Dilated Cardiomyopathy Intervention: Behavioral: Family Heart Talk Booklet Sponsors: Ray Hershberger; National Heart, Lung, and Blood Institute (NHLBI); National Human Genome Research Institute (NHGRI) Recruiting
Condition: Prostate Cancer Interventions: Drug: Degarelix; Drug: Leuprolide Sponsors: Ferring Pharmaceuticals; Memorial Sloan Kettering Cancer Center; Duke Clinical Research Institute Recruiting
Condition: Hemophilia Interventions: Biological: Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013; Biological: Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 Sponsors: American Thrombosis and Hemostasis Network; Shire; CSL Behring; Bioverativ Therapeutics Inc.; Bayer Recruiting
Conditions: Germ Cell Tumor; Teratoma; Choriocarcinoma; Germinoma; Mixed Germ Cell Tumor; Yolk Sac Tumor; Childhood Teratoma; Malignant Germ Cell Neoplasm; Extragonadal Seminoma; Non-seminomatous Germ Cell Tumor; Seminoma Interventions: Drug: paclitaxel; Drug: ifosfamide; Drug: cisplatin; Drug: pegylated G-CSF; Drug: G-CSF; Drug: carboplatin; Drug: etoposide phosphate; Procedure: stem cell reinfusion Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); European Organisation for Research and Treatment of Cancer - EORTC; Movember Foundation; Institute of Cancer Research (ICR), United Kingdom; Cancer Research UK; UNICANCER; Irish Group CTI Recruiting
Condition: Antiretroviral Toxicity Intervention: Sponsors: Harvard School of Public Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Mental Health (NIMH); National Heart, Lung, and Blood Institute (NHLBI); National Institute on Deafness and Other Communication Disorders (NIDCD); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute of Neurological Disorders and Stroke (NINDS); Tulane University School of Medicine; National Institute of Dental and Craniofacial Research (NIDCR); NIH Office of AIDS Research (OAR) Recruiting
Conditions: Severe Combined Immunodeficiency (SCID); Leaky SCID; Omenn Syndrome; Reticular Dysgenesis; ADA SCID; XSCID Intervention: Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Primary Immune Deficiency Treatment Consortium (PIDTC); Office of Rare Diseases (ORD); National Center for Advancing Translational Science (NCATS) Recruiting